Tamas L - Search Results

1

Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Fulop DB, Humli V, Szepesy J, Ott V, Reglodi D, Gaszner B, Nemeth A, Szirmai A, Tamas L, Hashimoto H, Zelles T, Tamas A. Fulop DB, et al. Among authors: tamas a, tamas l. Sci Rep. 2019 Oct 10;9(1):14598. doi: 10.1038/s41598-019-50775-z. Sci Rep. 2019. PMID: 31601840 Free PMC article.

2

Protective effect of rasagiline in aminoglycoside ototoxicity.

Polony G, Humli V, Andó R, Aller M, Horváth T, Harnos A, Tamás L, Vizi ES, Zelles T. Polony G, et al. Among authors: tamas l. Neuroscience. 2014 Apr 18;265:263-73. doi: 10.1016/j.neuroscience.2014.01.057. Epub 2014 Feb 6. Neuroscience. 2014. PMID: 24508748 Free article.

3

Usefulness of ultrasound-computer-craniocorpography in different vestibular disorders.

Szirmai A, Maihoub S, Tamás L. Szirmai A, et al. Among authors: tamas l. Int Tinnitus J. 2014;19(1):6-9. doi: 10.5935/0946-5448.20140002. Int Tinnitus J. 2014. PMID: 27186828

4

[Efficacy of assisted balance training in chronic vestibular vertigo].

Szirmai Á, Maihoub S, Tamás L. Szirmai Á, et al. Among authors: tamas l. Orv Hetil. 2018 Mar;159(12):470-477. doi: 10.1556/650.2018.31012. Orv Hetil. 2018. PMID: 29552927 Hungarian.

5

Analysis of GJB2 mutations and the clinical manifestation in a large Hungarian cohort.

Kecskeméti N, Szönyi M, Gáborján A, Küstel M, Milley GM, Süveges A, Illés A, Kékesi A, Tamás L, Molnár MJ, Szirmai Á, Gál A. Kecskeméti N, et al. Among authors: tamas l. Eur Arch Otorhinolaryngol. 2018 Oct;275(10):2441-2448. doi: 10.1007/s00405-018-5083-4. Epub 2018 Aug 9. Eur Arch Otorhinolaryngol. 2018. PMID: 30094485

6

[Possible effect of diabetes and hypertension on the quality of life of patients suffering from Ménière's disease].

Molnár A, Stefani M, Tamás L, Szirmai Á. Molnár A, et al. Among authors: tamas l. Orv Hetil. 2019 Jan;160(4):144-150. doi: 10.1556/650.2019.31256. Orv Hetil. 2019. PMID: 30661384 Hungarian.

7

[Etiological factors of sensorineural hearing loss in children after cochlear implantation].

Kecskeméti N, Gáborján A, Szőnyi M, Küstel M, Baranyi I, Molnár MJ, Tamás L, Gál A, Szirmai Á. Kecskeméti N, et al. Among authors: tamas l. Orv Hetil. 2019 May;160(21):822-828. doi: 10.1556/650.2019.31398. Orv Hetil. 2019. PMID: 31104499 Hungarian.

8

Intratympanically administered steroid for progressive sensorineural hearing loss in Ménière's disease.

Molnár A, Maihoub S, Tamás L, Szirmai Á. Molnár A, et al. Among authors: tamas l. Acta Otolaryngol. 2019 Nov;139(11):982-986. doi: 10.1080/00016489.2019.1658898. Epub 2019 Sep 9. Acta Otolaryngol. 2019. PMID: 31498001 Clinical Trial.

9

Conservative Treatment Possibilities of Ménière Disease, Involving Vertigo Diaries.

Molnár A, Maihoub S, Tamás L, Szirmai Á. Molnár A, et al. Among authors: tamas l. Ear Nose Throat J. 2021 Aug;100(7):536-542. doi: 10.1177/0145561319881838. Epub 2019 Oct 16. Ear Nose Throat J. 2021. PMID: 31617407 Free article.

10

[Typical characteristics of the symptoms of patients suffering from Ménière's disease and the multidisciplinary approach].

Molnár A, Maihoub S, Fent Z, Tamás L, Szirmai Á. Molnár A, et al. Among authors: tamas l. Orv Hetil. 2019 Dec;160(48):1915-1920. doi: 10.1556/650.2019.31568. Orv Hetil. 2019. PMID: 31760777 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page